查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2048264

血漿冷凍庫市場 - 全球產業規模、佔有率、趨勢、機會、預測：按類型、應用、地區和競爭格局分類，2021-2031年

Blood Plasma Freezer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Manual Defrost, Automatic Defrost, and Others), By Application (Hospitals, Laboratory, and Others), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 189 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球血漿冷凍庫市場預計將從 2025 年的 5.7261 億美元成長到 2031 年的 7.7528 億美元，複合年成長率為 5.18%。

該市場涵蓋專為維持低於攝氏-27度的溫度而設計的醫用冷藏系統，這對於血漿及其重要凝血因子的長期儲存至關重要。該領域的成長主要受全球血液疾病發病率上升以及由此產生的對血漿衍生治療方法的需求，以及開發中國家血庫基礎設施的蓬勃發展所驅動。此外，關於生物檢體可追溯性和安全性的嚴格監管要求，也日益推動醫療保健產業採用受監管的高性能保存解決方案。

市場概覽
預測期： 2027-2031
市場規模：2025年 5.7261億美元
市場規模：2031年 7.7528億美元
複合年成長率：2026-2031年 5.18%
成長最快的細分市場 自動除霜
最大的市場 北美洲

儘管市場有所成長，但仍面臨許多挑戰。主要障礙在於維持超低溫環境所需的巨額初始投資和持續營運成本，這給預算緊張的醫療機構帶來了沉重的經濟負擔。生物供應鏈固有的不穩定性進一步加劇了這種經濟壓力，要求完美的庫存管理。例如，美國血液中心2025年2月的區域數據顯示，美國南部近60%的受訪血液中心面臨嚴重的庫存短缺，凸顯了在資源匱乏的環境中，迫切需要可靠的儲存基礎設施來最大限度地減少浪費。

市場促進因素

全球血漿冷凍庫市場的主要驅動力是血漿衍生療法和生物製藥需求的不斷成長，這些療法和產品對於治療免疫力缺乏和出血性疾病至關重要。隨著臨床對關鍵免疫球蛋白和凝血因子的依賴性日益增強，血液採集機構被迫大幅擴容以應對捐血的激增。各國血液採集統計數據清楚地顯示了治療需求與低溫儲存基礎設施之間的直接關聯。例如，根據英國國家醫療服務體系（NHS）血液和移植中心於2025年7月發布的2024-2025會計年度年度報告和財務報表，原血漿採集量較上年度成長了34%，因此需要相應增加低溫儲存能力以確保產品療效。

同時，在醫療基礎設施大量投資的推動下，血庫網路和血液分離中心的蓬勃發展正顯著影響市場動態。製藥公司和政府正大力投資建造新設施，以實現供應鏈的自給自足，從而帶動了醫用冷藏系統的大規模採購。一個顯著的例子是，CSL Limited於2025年11月宣布了一項15億美元的美國製造地擴張計劃，該公司承諾投資約15億美元以加強其在美國的生產和採集業務。這項基礎建設熱潮直接惠及設備製造商，海爾生物醫療於2025年3月發布的2024會計年度財報也印證了低溫運輸設備行業的強勁成長，該財報顯示其總商業性達22.84億元。

市場挑戰

維持超低溫所需的高昂初始成本和持續營運成本是全球血漿冷凍庫市場的主要障礙。醫用冷凍設備需要大量的初始投資，並且會產生持續的能源成本，這對醫療機構來說是一項沉重的財務負擔。這種財務負擔嚴重限制了醫院和血庫對關鍵基礎設施進行現代化改造的能力，常常迫使它們延長老舊低效設備的運作，而不是投資購買新型高性能設備。因此，將血漿保存的臨床需求轉化為實際的設備銷售非常困難，尤其是在資源有限、預算優先排序至關重要的環境中。

這些經濟限制迫使醫療機構推遲關鍵的資本投資項目，直接阻礙了市場發展動能。隨著支出增加導致營運利潤率下降，採購部門不可避免地被迫推遲更換一些不那麼緊急的設備。根據美國醫院協會 (AHA) 預測，到 2025 年，絕大多數醫療機構管理者（94%）預計將推遲設備升級以應對財務壓力。這種普遍的採購決策延遲顯著降低了對新型血漿冷凍庫的即時需求，從而阻礙了低溫運輸網路的穩健擴張，並減緩了整體市場的成長軌跡。

市場趨勢

物聯網和雲端即時監控系統的整合正在從根本上改變全球血漿冷凍庫市場，有效解決了供應鏈可視性和檢體安全的關鍵漏洞。這些先進的數位化平台能夠持續遠端追蹤內部溫度和存量基準，以自動化資料流取代繁瑣的人工記錄，並確保嚴格遵守儲存規程。借助互聯感測器和集中式控制面板，血庫可以即時檢測溫度偏差和設備故障，從而避免高價值生物資產的災難性損失。這項技術進步正在帶來實際的營運改善。例如，根據海爾生物醫療於2025年4月發布的《智慧血城網路週年更新報告》，試點設施實施智慧管理系統後，透過精準的即時庫存追蹤和更高的處理效率，血液浪費減少了20%。

同時，在嚴格的環境法規和醫院永續營運需求的推動下，環保天然冷媒和低全球暖化潛值（GWP）解決方案的日益普及，正在重塑整個市場的產品標準。製造商正在逐步淘汰氫氟碳化合物（HFC），轉而採用碳氫化合物冷卻系統，這些系統不僅具有更優異的動態性能，還能顯著降低醫用冷凍和冷凍設備的碳足跡。新的能源效率要求進一步加速了這項轉型，鼓勵用高性能、環保技術取代老舊設備。例如，美國環保署（EPA）於2025年6月發布的《實驗室冷藏庫和冷凍庫能源之星計畫要求2.0版》制定了一項新的認證標準，要求認證型號的能耗比傳統標準設備降低約37%，從而為醫療領域的能源效率樹立了新的標竿。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：冷凍庫全球市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（手動除霜、自動除霜、其他）
    • 按應用（醫院、檢查室、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美冷凍庫市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲血漿冷凍庫市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區血漿冷凍庫市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲血漿冷凍庫市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲血漿冷凍庫市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布

第13章：全球血漿冷凍庫市場：SWOT分析

第14章：波特五力分析

  • 產業內部的競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Haier Inc.
  • PHC Holdings Corporation
  • Thermo Fisher Scientific, Inc.
  • Dometic Group AB
  • Helmer Scientific Inc.
  • Glen Dimplex Home Appliances Limited
  • Changhong Meiling Co.,Ltd.
  • Felix Storch, Inc.
  • Follett Corporation
  • Jointlab Srl

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27635

The Global Blood Plasma Freezer Market is projected to grow from USD 572.61 Million in 2025 to USD 775.28 Million by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 5.18%. This market encompasses medical-grade refrigeration systems specifically designed to maintain temperatures below negative twenty-seven degrees Celsius, crucial for the long-term preservation of plasma and its vital clotting factors. Growth in this sector is primarily fueled by a rising global incidence of hematological disorders and the subsequent demand for plasma-derived therapies, alongside the robust expansion of blood bank infrastructure in developing countries. Furthermore, strict regulatory requirements concerning the traceability and safety of biological samples increasingly drive the adoption of compliant, high-performance storage solutions across the healthcare industry.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 572.61 Million
Market Size 2031USD 775.28 Million
CAGR 2026-20315.18%
Fastest Growing SegmentAutomatic Defrost
Largest MarketNorth America

Despite this growth, market expansion faces significant challenges, mainly due to the substantial acquisition and ongoing operational costs associated with maintaining ultra-low temperatures, which impose considerable financial strain on budget-constrained medical facilities. This financial pressure is intensified by the inherent volatility of biological supply chains, demanding impeccable inventory management. For instance, in February 2025, regional data from America's Blood Centers revealed that nearly sixty percent of surveyed blood centers in the southern United States experienced critical inventory deficits, highlighting the urgent need for dependable preservation infrastructure to minimize waste in resource-limited environments.

Market Driver

The primary driver propelling the Global Blood Plasma Freezer Market is the increasing demand for plasma-derived therapies and biopharmaceuticals, which are essential for treating immune deficiencies and bleeding disorders. As clinical reliance on vital immunoglobulins and clotting factors grows, collection organizations are compelled to significantly expand their storage capacities to accommodate surging donation volumes. The direct link between therapeutic demand and cold storage infrastructure is clearly visible in national collection statistics; for example, NHS Blood and Transplant's 'Annual Report and Accounts 2024-25', published in July 2025, indicated a 34% rise in source plasma collected over the preceding year, necessitating a parallel increase in ultra-low temperature storage capacity to ensure product viability.

Concurrently, the vigorous expansion of blood bank networks and apheresis centers, fueled by substantial investments in healthcare infrastructure, is profoundly influencing market dynamics. Pharmaceutical companies and governments are investing heavily in new facilities to achieve supply chain sovereignty, leading to significant procurement orders for medical-grade refrigeration systems. A notable example is CSL Limited's November 2025 announcement of a "$1.5 Billion U.S. Manufacturing Expansion Launched," committing approximately $1.5 billion to enhance manufacturing and collection operations within the United States. This infrastructure boom directly benefits equipment manufacturers, as evidenced by Haier Biomedical's '2024 Annual Performance Report' in March 2025, which reported a total revenue of RMB 2.284 billion, signaling strong commercial growth in the cold chain equipment sector.

Market Challenge

The high acquisition and ongoing operational costs associated with maintaining ultra-low temperatures serve as a primary impediment to the Global Blood Plasma Freezer Market. Medical-grade refrigeration units demand substantial upfront capital investment and incur continuous energy expenses, creating a significant economic burden for healthcare facilities. This financial strain severely limits the capacity of hospitals and blood banks to allocate funds for essential infrastructure modernization, often forcing them to prolong the operational life of older, less efficient equipment rather than investing in newer, high-performance models. Consequently, the market struggles to convert the inherent clinical demand for plasma storage into actual equipment sales, particularly within resource-constrained settings where budget prioritization is critical.

This economic constraint directly hinders market momentum by compelling institutions to defer crucial capital projects. As operational margins diminish due to escalating expenses, procurement departments inevitably postpone non-urgent hardware replacements. According to the American Hospital Association, in 2025, an overwhelming ninety-four percent of healthcare administrators anticipated delaying equipment upgrades to manage financial pressures. Such widespread postponement of purchasing decisions significantly reduces the immediate demand for new plasma freezers, thereby impeding the robust expansion of cold chain networks and slowing the overall growth trajectory of the market.

Market Trends

The integration of IoT and cloud-based real-time monitoring systems is fundamentally transforming the Global Blood Plasma Freezer Market, effectively addressing critical vulnerabilities in supply chain visibility and sample safety. These sophisticated digital platforms enable continuous remote tracking of internal temperatures and inventory levels, replacing laborious manual logging with automated data streams that ensure strict adherence to storage protocols. By employing connected sensors and centralized dashboards, blood banks can instantly detect temperature excursions and equipment malfunctions, thereby preventing the catastrophic loss of high-value biological assets. This technological evolution is yielding tangible operational improvements; for instance, Haier Biomedical's 'Smart Blood City Network Anniversary Update' in April 2025 reported that the deployment of their intelligent management systems in pilot facilities resulted in a 20% reduction in blood wastage, achieved through precise real-time inventory tracking and enhanced handling efficiency.

Simultaneously, the increasing adoption of eco-friendly natural refrigerants and low-Global Warming Potential (GWP) solutions is reshaping product standards across the market, driven by stringent environmental regulations and the imperative for sustainable hospital operations. Manufacturers are progressively phasing out hydrofluorocarbons (HFCs) in favor of hydrocarbon-based cooling systems, which offer superior thermodynamic properties while significantly reducing the carbon footprint of medical cold storage. This transition is further accelerated by new efficacy mandates that incentivize the replacement of legacy units with high-performance, green technology. For example, the U.S. Environmental Protection Agency's 'ENERGY STAR Program Requirements for Laboratory Grade Refrigerators and Freezers Version 2.0', published in June 2025, established new certification standards requiring qualifying models to consume approximately 37% less energy than standard conventional units, setting a new benchmark for energy efficiency in the healthcare sector.

Key Market Players

  • Haier Inc.
  • PHC Holdings Corporation
  • Thermo Fisher Scientific, Inc.
  • Dometic Group AB
  • Helmer Scientific Inc.
  • Glen Dimplex Home Appliances Limited
  • Changhong Meiling Co.,Ltd.
  • Felix Storch, Inc.
  • Follett Corporation
  • Jointlab S.r.l.

Report Scope

In this report, the Global Blood Plasma Freezer Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Plasma Freezer Market, By Type

  • Manual Defrost
  • Automatic Defrost
  • Others

Blood Plasma Freezer Market, By Application

  • Hospitals
  • Laboratory
  • Others

Blood Plasma Freezer Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Plasma Freezer Market.

Available Customizations:

Global Blood Plasma Freezer Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Plasma Freezer Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Manual Defrost, Automatic Defrost, Others)
    • 5.2.2. By Application (Hospitals, Laboratory, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Blood Plasma Freezer Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Blood Plasma Freezer Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Blood Plasma Freezer Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Blood Plasma Freezer Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Blood Plasma Freezer Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Blood Plasma Freezer Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Blood Plasma Freezer Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Blood Plasma Freezer Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Blood Plasma Freezer Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Blood Plasma Freezer Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Blood Plasma Freezer Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Blood Plasma Freezer Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Blood Plasma Freezer Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Blood Plasma Freezer Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Blood Plasma Freezer Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Blood Plasma Freezer Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Blood Plasma Freezer Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Blood Plasma Freezer Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Blood Plasma Freezer Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Blood Plasma Freezer Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. South America Blood Plasma Freezer Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Blood Plasma Freezer Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Blood Plasma Freezer Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Blood Plasma Freezer Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Blood Plasma Freezer Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Haier Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. PHC Holdings Corporation
  • 15.3. Thermo Fisher Scientific, Inc.
  • 15.4. Dometic Group AB
  • 15.5. Helmer Scientific Inc.
  • 15.6. Glen Dimplex Home Appliances Limited
  • 15.7. Changhong Meiling Co.,Ltd.
  • 15.8. Felix Storch, Inc.
  • 15.9. Follett Corporation
  • 15.10. Jointlab S.r.l.

16. Strategic Recommendations

17. About Us & Disclaimer